Markets on Edge as AI Hype Meets Hard Questions

Macro Mood

Chip stocks drove the session's narrative. The S&P 500 and Nasdaq closed lower as a semiconductor rebound failed to hold. AI-related names have come under pressure, and the Bank for International Settlements added fuel to that fire — warning that AI "exuberance" risks ending in a prolonged investment bust. Weak returns, the BIS said, could trigger a sharp pullback in tech funding with global ripple effects.

Earnings Watch

This week brings three big consumer names. NKE reports Q4 FY2026 results Monday after the close. Expectations are low after sluggish China sales and mounting competition. STZ — Constellation Brands — also releases Q1 FY2027 numbers Monday, with tariff impacts on Mexican beer imports in focus. GIS — General Mills — follows Tuesday. Pricing commentary will be key as consumers keep trading down to private labels.

Short Sellers & Deals

WOLF — Wolfspeed — remains the market's most extreme short. SI % of FF hit 129.9%, with zero shares left to borrow. Separately, ARES Management is targeting over $1.7 billion in a new Asia private credit raise — a sign that institutional capital is still chasing yield outside public equities.

Legal & Regulatory

MSFT — Microsoft — and OpenAI now face a copyright lawsuit from nearly 400 newspaper publishers. The case could reshape how AI firms license training data. CTVA — Corteva — made two moves: naming a new independent chair and targeting a seed and genetics spin-off for Q4 2026. PRAX — Praxis Precision Medicines — saw the FDA extend its review date for relutrigine to December 27, citing a major amendment submission with no new safety concerns.

Europe in Focus

European stocks slid today. The defense sector bucked the trend after Ukraine ratified a $105 billion EU loan deal. Gas storage anxiety also returned — EU facilities risk entering winter at a 15-year low refill rate, adding pressure on energy markets heading into Q3.